SureTrader
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

<u>Scripts Update for Week Ending 29/09</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Sam81 Member Profile
 
Followed By 14
Posts 625
Boards Moderated 0
Alias Born 06/26/14
160x600 placeholder
Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018 GlobeNewswire Inc. - 2/20/2018 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2018 5:02:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 5:27:59 PM
Amarin Prices Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/30/2018 8:58:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/29/2018 4:08:42 PM
Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/29/2018 4:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2018 6:01:14 PM
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events GlobeNewswire Inc. - 1/23/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/17/2018 5:59:57 PM
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China GlobeNewswire Inc. - 1/17/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 6:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 6:01:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2018 4:57:25 PM
Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook GlobeNewswire Inc. - 1/4/2018 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:34:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:33:51 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 12/22/2017 4:13:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/21/2017 4:04:15 PM
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018 GlobeNewswire Inc. - 12/19/2017 6:00:00 AM
Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco GlobeNewswire Inc. - 12/18/2017 4:30:00 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 12/4/2017 4:48:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2017 9:04:12 AM
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular ... GlobeNewswire Inc. - 11/14/2017 4:30:00 PM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Pat... GlobeNewswire Inc. - 11/13/2017 4:30:00 PM
Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical ... GlobeNewswire Inc. - 11/13/2017 6:00:00 AM
Sam81   Friday, 10/06/17 04:10:51 AM
Re: None
Post # of 122913 
Scripts Update for Week Ending 29/09
ATH in TRx & NRx Market Share

V
TRx: 24,339 {vs 24,604; -1.08%} Sector -1.44% -- {2nd ATH}
NRx: 9,394 {vs 9,431; -0.39%} Sector -1.65% -- {4th ATH}
Ref: 14,945 {vs 15,173; -1.50%} Sector -1.31% -- {2nd ATH}

GenL
TRx: 50,143 {vs 50,900; -1.49%}
NRx: 18,621 {vs 19,051; -2.26%}

L
TRx: 4,032 {vs 4,159; -3.05%}
NRx: 1,694 {vs 1,726; -1.85%}

V TRx Market Share: 31.00% vs 30.89% -- ATH
V NRx Market Share: 31.62% vs 31.22% -- ATH
V Ref Market Share: 30.62% vs 30.68% -- {2nd ATH}


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist